TheTradeXchange
Posted - 17 hours ago
$PHG - Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities
DonCorleone77
Posted - 2 weeks ago
$PHG Philips removed from European Conviction List at Goldman Sachs Goldman Sachs analysts removed Philips from the firm's European Conviction List as part of its monthly update.
cdsnuts93
Posted - 10/31/24
@Icemanja Back to the conversation of Suitors. I think Royal Phillips $PHG could be a match. They just rolled out a stent that helps a different issue in the CVI realm. https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/philips-launches-duo-venous-stent-system-for-treatment-of-symptomatic-venous-outflow-obstruction.html#
cubie
Posted - 10/29/24
@EBE_Day @indievestments @judgeyoung2 @Alvi722 @jenbunn @Ollip @ribbey @TraderRapp @tonyctl @lukenight I missed this post too ebe 🙈😅, did $phg work this morning?
Himel92
Posted - 10/29/24
The Last month Performance for $PHG Opening Price: $32.76
Closing Price: $26.62
Highest Price: $32.91
Lowest Price: $26.09
Percentage Change: -18.74% Data provider: AITX
briefingcom
Posted - 10/29/24
$PHG: Philips to further roll out RATE: AI for Early Infection Detection at U.S. Department of defense through four-year, $25 million contract. Over the next four years, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, will invest $25 million to make the technology more accessible in the field.
codefocus
Posted - 10/29/24
$BYND and $OTLY earnings next week 💰
$DOGE.X and $BBKCF woke up!! 💰
Glad I sold $PHG before the drop, though will jump in again later.
tradingtwenty
Posted - 10/29/24
Top 5 oversold stocks that have trended in the past 24 hours: $CPRI 10.74🔥 $PHG 21.83 $ICLR 23.81 $NEP 24.29 $NVO 28.47 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past
briefingcom
Posted - 10/29/24
$PHG: Philips (+2%) upgraded to Hold from Underperform at Jefferies https://www.briefing.com/calendars/updown?Filter=Upgrades
upgrayeddd
Posted - 10/28/24
$PHG It's wild how so many traders are obsessed with China.
Stilzittenenbijkopen
Posted - 10/28/24
$PHG loading more! Easy rebound🚀
GambitMentality
Posted - 10/28/24
Today’s #StockMarket EOD Biggest Losers by %, led by $DOGZ $TMTC and $PHG to lead the TOP 3
TheDayTradingAcademy
Posted - 10/28/24
Philips $PHG said on Monday that demand in China slumped significantly in recent months, forcing the Dutch medical devices maker to lower its sales outlook for the year & sending its European shares down -16% at €24.61 ($26.61), in their biggest 1 day loss in 26 years. The company said it had been hit by a deterioration of consumer confidence in China & by an ongoing state-led anti-corruption campaign there which dragged down orders from Chinese hospitals. The stock is down -9.56% in the past 3 months, but up +20.71% in 2024 & +44.92% y/y, with a market cap of €27.5B ($29.74B).
stockleapp
Posted - 10/28/24
$PHG Philips gets hammered after Q3 earnings: EPS: €0.32 (Est. €0.35) Revenue: €4.4B (Est. €4.54B) “In the quarter, demand from hospitals and consumers in China further deteriorated", "We have adjusted our full-year sales outlook to reflect the continued impact from China" - Roy Jakobs, CEO
Jamesiam
Posted - 10/28/24
$PHG this was $19 a few months ago
swingingtech
Posted - 10/28/24
$PHG
https://wallstreetwaves.com/philips-stock-a-deep-dive-into-oversold-conditions-phg/
briefingcom
Posted - 10/28/24
$PHG: A surprising turn of events in China during Q3 battered Philips (-16.3%), spurring a sharp reduction in its FY24 comparable sales growth outlook. Last quarter, the medical and personal health device maker was optimistic that business in China, which comprises around 10% of revenue, had stabilized, adding that the region should gradually contribute to positive order growth over the coming quarters. Given this context, investors are stunned by the fact that not only did China fail to add to order growth in the quarter, but that conditions deteriorated, driving today's significant sell-off. PHG missed earnings estimates in Q3 by a few pennies, a common occurrence for the company, making this development not overly surprising. https://www.briefing.com/story-stocks/archive/2024/10/28/philips-encounters-deteriorating-conditions-in-china-in-q3-clips-fy24-guidance-(phg)?utm_campaign=storystocks&utm_medium=social&utm_source=st&utm_content=link
MoonInvestmentsss
Posted - 10/28/24
$PHG $27.74 minimum.
MoonInvestmentsss
Posted - 10/28/24
$LUNR $AMZN $INTC $PHG $IBRX This is how money is made. Riding the bullish waves!🚀
MoonInvestmentsss
Posted - 10/28/24
$LUNR $INTC $PHG $IBRX BUYs.
cubie
Posted - 10/28/24
@EBE_Day @indievestments @Alvi722 @judgeyoung2 @jenbunn @Ollip @ribbey @TraderRapp @tonyctl @lukenight $phg sure wasn't ebe. u didnt mention it till after close? 😬🙄.
ribbey
Posted - 10/28/24
@cubie @lukenight @indievestments @Alvi722 @judgeyoung2 @jenbunn @Ollip @EBE_Day @TraderRapp @tonyctl $PHG er 👀
wallstengine
Posted - 10/28/24
$PHG | Philips Q3 FY24 Earnings Highlights 🔹 Adjusted EPS: €0.32 (Est. €0.35) 🔴 🔹 Adj EBITA: €516M (Est. €535.1M) 🔴; Margin 11.8% 🔹 Sales: €4.38B (Est. €4.58B) 🔴; Flat Comp Sales Growth CUTS FY24 Guidance: 🔹 Comparable Sales Growth: 0.5%-1.5% (Prev. 3%-5%) 🔴 🔹 Free Cash Flow: ~€900M (Prev. €900M-€1.1B) 😕 🔹 Adjusted EBITA Margin: ~11.5% Business Performance & Outlook: 🔹 Order Intake: DOWN -2%, impacted by weak China demand 🔹 China: Significant deterioration in demand led to revised sales outlook 🔹 Non-China Markets: Steady growth of 3%-5%
DonCorleone77
Posted - 10/28/24
$PHG Philips sees FY24 adjusted EDITDA margin 11.5% The company said, "The significant deterioration in China demand leads to an updated comparable sales growth outlook range of 0.5-1.5% for the full year 2024. Comparable sales growth outside of China remains within the 3-5% range. Adjusted EBITA margin is expected to be around 11.5%, the upper end of the range, with free cashflow at around EUR 0.9 billion, at the lower end of the range. Within an ongoing challenging macro environment, Philips remains focused on successfully executing its three-year plan to drive operational improvement and create value with sustainable impact. The uncertainties signaled in earlier quarters have intensified in China and are expected to continue. The outlook excludes the potential impact of the ongoing Philips Respironics-related legal proceedings, including the investigation by the US Department of Justice."
DonCorleone77
Posted - 10/28/24
$PHG Philips reports Q3 EPS 32 vs. 32c last year Reports Q3 revenue EUR 4.38B vs. EUR 4.47B. Group comparable sales were flat. Comparable order intake in the quarter declined 2%. The company said, ""In the quarter, demand from hospitals and consumers in China further deteriorated, while we continue to see solid growth in other regions. We have adjusted our full-year sales outlook to reflect the continued impact from China. Strong improvement in profitability was driven by progress on our execution priorities, productivity measures and the improved margins of our AI-driven, industry-leading innovations. Within a challenging macro environment, we remain focused on successfully executing our three-year plan to fully capture growth and margin expansion opportunities. With patient safety as our number one priority, we are committed to delivering better care for more people."
Okadarlan
Posted - 10/28/24
$PHG still freerolling and nice sale.
EBE_Day
Posted - 10/25/24
@cubie @indievestments @judgeyoung2 @Alvi722 @jenbunn @Ollip @ribbey @TraderRapp @tonyctl @lukenight none of my strangles for Monday got filled $HIG $PHG $WKC I’m sure gonna regret not paying up
eWhispers
Posted - 10/25/24
#earnings before the open on Monday, October 28, 2024 https://www.earningswhispers.com/calendar $ON $PHG $PRCT $CNP $CX
RocketGo
Posted - 10/25/24
$PHG why drop so much today?
LauriceGeel
Posted - 1 month ago
$PHG advances healthcare tech with its innovations in imaging systems, patient monitoring, and diagnostics. Powered by FAAS.